Advanced Search

Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2008 December;60(6) > Minerva Pediatrica 2008 December;60(6):1417-35



A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry

Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532

Frequency: Bi-Monthly

ISSN 0026-4946

Online ISSN 1827-1715


Minerva Pediatrica 2008 December;60(6):1417-35


Metchnikoff and the centenary of probiotics: an update of their use in gastroenteric pathology during the age of development

Caramia G.

Emeritus Head of Neonatology and Pediatric Department Specialized Pediatric Hospital “G. Salesi” Ancona, Italy

Acute gastroenteritis, antibiotic-associated diarrhea, diarrhea due to Clostridium difficile and traveller’s diarrhea, Helicobacter pylori infection and intestinal inflammatory diseases are primitive and/or secondary pathological conditions that alter the intestinal mucosa and microbiota. For years researchers have searched for solutions to restore and rebalance normal transit and intestinal flora. Elia Metchnikoff was the first one to introduce oral bacteriotherapy, that uses very efficient microorganisms that prevent putrefaction and aging. Oral bacteriotherapy has now evolved in probiotics, whose helpful action to prevent and treat some gastroenteric pathologies is currently being studied.

language: English


top of page